18p-FDG PET is superior to67Ga SPECT in the staging of non-Hodgkin’s lymphoma

Yamamoto, Fumiyasu; Tsukamoto, Eriko; Nakada, Kunihiro; Takei, Toshiki; Asaka, Masahiro; Tamaki, Nagara

doi:10.1007/bf02984570

Cited by 35 publications

(13 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Both the MET and FDG uptakes were evaluated using the maximum standardized uptake value (SUV max ), as reported earlier [8,9]. Nodule size was determined using the maximal diameter of the nodule on CT.…”

Section: Discussionmentioning

confidence: 99%

Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis

et al. 2007

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis

et al. 2007

Self Cite

View full text Add to dashboard Cite

show abstract

“…FDG PET has high sensitivity (88%-100%) for detection and staging of Hodgkin disease and non-Hodgkin lymphomas (2,13,19) and is rapidly replacing 67 Ga scintigraphy as the functional imaging method of choice (20). Advantages of FDG PET over 67 Ga scintigraphy are higher accuracy, better spatial resolution, same-day imaging, and a lower radiation dose (21). In addition, FDG PET has high diagnostic accuracy for differentiating recurrent or residual tumor from scar tissue and can help predict the response to therapy.…”

Section: Functional Imagingmentioning

confidence: 97%

Cross-sectional Imaging of Extranodal Involvement in Abdominopelvic Lymphoproliferative Malignancies

Leite

Kased²,

Hanna³

et al. 2007

RadioGraphics

104

View full text Add to dashboard Cite

Extranodal lymphoproliferative diseases are common, and their prevalence is increasing. Non-Hodgkin lymphomas and Hodgkin disease, in particular, frequently involve extranodal structures in the abdomen and pelvis, including both the solid organs (liver, spleen, kidneys, and pancreas) and the hollow organs of the gastrointestinal tract. Because virtually any abdominopelvic tissue may be involved, many different imaging manifestations are possible, and lymphoproliferative diseases may mimic other disorders. Familiarity with the imaging manifestations that are diagnostically specific for extranodal lymphoproliferative diseases is important because imaging plays an important role in the noninvasive management of disease. However, a definitive diagnosis requires a biopsy (of bone marrow, a lymph node, or a mass), a peripheral blood analysis, and other laboratory tests. In patients with known disease, the goals of imaging are staging, evaluation of response to therapy, and identification of new or recurrent disease or of complications of therapy. In patients without known disease, imaging permits a provisional diagnosis.

show abstract

“…FDG-PET has been regarded as the gold standard for lymphoma imaging (22). However, insufficient data are available about the use of FDG-PET for primary pulmonary lymphomas.…”

mentioning

confidence: 99%

Primary pulmonary non-Hodgkin’s lymphoma: ten cases with a review of the literature

Kocatürk¹,

Seyhan²,

Günlüoğlu³

et al. 2012

Tuberk Toraks

View full text Add to dashboard Cite

Bulgular:Hastaların sekizi erkek ikisi kadın olup, ortanca yaş 50 (aralık 29-76) Lymphomas, which are malignant tumors of lymphoid tissue, may rarely be detected as a form of primary lung disease, although they usually affect the lungs secondarily through hematogenous dissemination or direct invasion from hilar/mediastinal lymph nodes. Primary pulmonary lymphomas (PPL) represent < 1% of primary malignant lung tumors, < 1% of lymphomas and only 3-4% of extranodal lymphomas (1-3).PPLs originate from mucosa-associated lymphoid tissue (MALT) (4). These tumors may be a type of Hodgkin's or non-Hodgkin's lymphoma (NHL). The majority of PPLs consists of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and diffuse large B-cell lymphomas (DLBCL), which are types of NHLs (5).Pulmonary MALT lymphoma usually has an indolent course, remaining localized to the lung for long periods before dissemination. However, DLBCL is less frequent and is believed to have a poorer prognosis than MALT lymphoma (6,7).Although some studies have reported this rare disease, the histopathological features, clinical course, optimal treatment, role of surgery, and prognostic factors are not well defined (8)(9)(10)(11)(12). In this study, we assessed the clinical, radiological, diagnostic, and pathological features of our cases with primary pulmonary non-Hodgkin's lymphoma (PPNHL), along with prognosis and treatment results. MATERIALS and METHODSOur clinical (surgery clinic) database records were reviewed retrospectively, as we attempted to find patients with a diagnosis of PPNHL between January 2004 and February 2009. As this was a retrospective study, ethics committee acceptance not needed. Scientific Study Committee of our hospital reviewed and approved the database. We used the following criteria to diagnose PPNHL (10,13): Information on demographic variables, clinical and radiological findings, medical history, the procedures applied to patients to diagnose and treat, and histopathological findings of the tumors was gathered through the clinical database and patient files.

show abstract

18p-FDG PET is superior to67Ga SPECT in the staging of non-Hodgkin’s lymphoma

Abstract: 18F-FDG PET detected significantly more lesions particularly small lesions than 67Ga SPECT. Thus, 18F-FDG PET is considered to be superior to 67Ga SPECT in the staging of non-Hodgkin' s lymphoma.

Cited by 35 publications

References 26 publications

Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis

Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis

Cross-sectional Imaging of Extranodal Involvement in Abdominopelvic Lymphoproliferative Malignancies

Primary pulmonary non-Hodgkin’s lymphoma: ten cases with a review of the literature

Contact Info

Product

Resources

About